Cancer Finance 2011
The year 2011 marked a pivotal time in cancer finance, characterized by shifts in research funding priorities, emerging treatment costs, and growing discussions surrounding patient access and affordability. While a precise dollar figure for total global cancer spending in 2011 is elusive due to fragmented data collection and varying definitions, trends observed during that period significantly shaped the landscape of cancer care as we know it today.